Genipin normalizes depression-like behavior induced by prenatal stress through inhibiting DNMT1

Area of Science:

• Neuroscience
• Pharmacology
• Genetics

Background:

• Current synthetic antidepressants have limitations, including slow response, remission, and side effects.
• There is a need for novel antidepressants with improved efficacy and safety profiles.
• Genipin, from Gardenia jasminoides, has shown potential antidepressant effects, but its mechanisms are not fully understood.

Purpose of the Study:

• To investigate the molecular mechanisms underlying the antidepressant effects of genipin.
• To evaluate genipin's efficacy in a mouse model of depression induced by prenatal stress.

Main Methods:

• Utilized a prenatal stress (PRS) mouse model to induce depression-like behaviors.
• Administered genipin to PRS mice and assessed behavioral changes.
• Investigated the effects of genipin on DNA methylation and gene expression in the hippocampus.

Main Results:

• Genipin effectively corrected depression-like behaviors in PRS mice.
• Genipin inhibited DNA methyltransferase 1 (DNMT1) activity.
• Genipin normalized the expression of brain-derived neurotrophic factor (BDNF) in the hippocampus of PRS mice.

Conclusions:

• Genipin exerts antidepressant effects by inhibiting DNMT1, leading to DNA demethylation.
• This mechanism results in the normalization of reduced BDNF expression in the hippocampus.
• Genipin represents a promising therapeutic agent for depression, particularly stress-related forms.